Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res Biosynthesis and production of a soluble form in human cultured endothelial cells, FEBS Lett, vol.47, issue.421, pp.841-845, 1987. ,
CD146 short isoform increases the proangiogenic potential of endothelial progenitor cells in vitro and in vivo, Circ. Res. J.; Nollet, M, vol.107, pp.66-75, 2010. ,
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors, Oncogene, vol.35, pp.5489-5500, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01456904
Soluble CD146 displays angiogenic properties and promotes neovascularization in experimental hind-limb ischemia, Blood, vol.115, pp.3843-3851, 2010. ,
CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, issue.5, pp.746-753, 2009. ,
DOI : 10.1161/ATVBAHA.108.183251
URL : https://hal.archives-ouvertes.fr/hal-00428932
Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma, Cancer Res, vol.139, issue.62, pp.65-75, 1991. ,
A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth, Blood, vol.102, issue.1, pp.184-191, 2003. ,
DOI : 10.1182/blood-2002-04-1004
URL : http://www.bloodjournal.org/content/bloodjournal/102/1/184.full.pdf
A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule, Oncotarget, vol.8, issue.68 ,
DOI : 10.18632/oncotarget.22736
URL : https://hal.archives-ouvertes.fr/hal-01766676
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma, PLOS ONE, vol.18, issue.2, p.165382, 2016. ,
DOI : 10.1371/journal.pone.0165382.g006
HEMCAM, an adhesion molecule expressed by c-kit+ hemopoietic progenitors, The Journal of Cell Biology, vol.135, issue.6, pp.1655-1668, 1996. ,
DOI : 10.1083/jcb.135.6.1655
URL : http://jcb.rupress.org/content/jcb/135/6/1655.full.pdf
Visualization of CD146 dimerization and its regulation in living cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1773, issue.4, pp.1773-513, 2007. ,
DOI : 10.1016/j.bbamcr.2007.01.009
Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas, Proc. Natl. Acad. Sci. U.S.A. 2015. [CrossRef] ,
Genomic organization of the melanoma-associated glycoprotein MUC18: implications for the evolution of the immunoglobulin domains., Proc. Natl. Acad. Sci, pp.8514-8518, 1993. ,
DOI : 10.1073/pnas.90.18.8514
Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines ,
and an Increase in Tumor Growth and Metastasis of Human Melanoma Cells, Journal of Biological Chemistry, vol.2, issue.26, pp.16501-16508, 1998. ,
DOI : 10.1073/pnas.93.25.14586
Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells, Oncogene, vol.15, issue.17, pp.2069-2075, 1997. ,
DOI : 10.1038/sj.onc.1201358
CD166/Activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion, Neuro-Oncology, vol.14, issue.6, pp.1254-1264, 2012. ,
DOI : 10.1158/1078-0432.CCR-07-0428
Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability, Gene, vol.265, issue.1-2, pp.133-145, 2001. ,
DOI : 10.1016/S0378-1119(01)00349-3
CD146 Promoter Polymorphism (rs3923594) Is Associated with Recurrence of Clear Cell Renal Cell Carcinoma in Chinese Population, Disease Markers, vol.2017, 2017. ,
DOI : 10.1016/j.eururo.2015.04.018
Expression of gp130 in Tumors and Inflammatory Disorders of the Skin: Formal Proof of its Identity as CD146 (MUC18, Mel-CAM), Journal of Investigative Dermatology, vol.28, issue.Pt 1, pp.353-363, 2005. ,
DOI : 10.1016/j.cdp.2003.12.006
Protein expression analysis of ALCAM and CEACAM6 in breast cancer metastases reveals significantly increased ALCAM expression in metastases of the skin, Journal of Clinical Pathology, vol.64, issue.2, pp.146-152, 2011. ,
DOI : 10.1136/jcp.2010.082602
Expression and Functional Analysis of a Novel Isoform of Gicerin, an Immunoglobulin Superfamily Cell Adhesion Molecule, Journal of Biological Chemistry, vol.270, issue.48, pp.28681-28687, 1995. ,
DOI : 10.1074/jbc.270.48.28681
Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration, Thrombosis and Haemostasis, vol.90, pp.915-920, 2003. ,
DOI : 10.1160/TH02-11-0285
Soluble CD146 is generated by ectodomain shedding of membrane CD146 in a calcium-induced, matrix metalloprotease-dependent process, Microvascular Research, vol.78, issue.3, pp.325-331, 2009. ,
DOI : 10.1016/j.mvr.2009.06.012
A dileucine motif targets MCAM-l cell adhesion molecule to the basolateral membrane in MDCK cells, FEBS Letters, vol.22, issue.15, pp.3649-3656, 2006. ,
DOI : 10.1038/sj.onc.1206819
Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion, Blood, vol.98, issue.13, pp.3677-3684, 2001. ,
DOI : 10.1182/blood.V98.13.3677
Involvement of Gicerin in the Extension of Microvilli, Experimental Cell Research, vol.271, issue.2, pp.269-276, 2001. ,
DOI : 10.1006/excr.2001.5393
al. Expression of CD146 in Adult and Children's Acute B Cell Lymphoblastic Leukemia and Its Significance, Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017, pp.30-34 ,
URL : https://hal.archives-ouvertes.fr/jpa-00254673
Hypermethylation of MCAM gene is associated with advanced tumor stage in prostate cancer, The Prostate, vol.34, issue.4, pp.418-426, 2008. ,
DOI : 10.1093/oxfordjournals.epirev.a000782
Direct correlation between MUC18 expression and metastatic potential of human melanoma cells, Melanoma Research, vol.3, issue.1, pp.35-41, 1993. ,
DOI : 10.1097/00008390-199304000-00006
Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice, International Journal of Cancer, vol.10, issue.6, pp.951-955, 1999. ,
DOI : 10.1007/BF00132752
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis, Cancer Res, vol.57, pp.2295-2303, 1997. ,
The role of N-Cadherin, MCAM, and ??3 integrin in melanoma progression, proliferation, migration and invasion, Cancer Biology & Therapy, vol.5, issue.10, pp.1375-1382, 2006. ,
DOI : 10.4161/cbt.5.10.3241
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients, British Journal of Dermatology, vol.13, issue.2, pp.338-344, 2009. ,
DOI : 10.1111/j.1365-2133.2008.08929.x
Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy, Journal of Plastic, Reconstructive & Aesthetic Surgery, vol.61, issue.3, pp.61-265, 2008. ,
DOI : 10.1016/j.bjps.2007.04.010
Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells, Gene, vol.327, issue.2, pp.201-213, 2004. ,
DOI : 10.1016/j.gene.2003.11.018
MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells, Tumor Biology, vol.9, issue.5, pp.1619-1628, 2012. ,
DOI : 10.1038/sj.cdd.4400987
The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma, Am. J. Pathol, vol.151, pp.745-751, 1997. ,
Chabannon, C. CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines, R1. [CrossRef], 2009. ,
METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells, Gene, vol.492, issue.1, pp.229-238, 2012. ,
DOI : 10.1016/j.gene.2011.10.024
CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer, International Journal of Molecular Sciences, vol.43, issue.5, pp.6399-6406, 2012. ,
DOI : 10.1016/j.humpath.2011.07.003
MCAM/CD146 promotes tamoxifen resistance in breast cancer cells through induction of epithelial???mesenchymal transition, decreased ER?? expression and AKT activation, Cancer Letters, vol.386, issue.386, pp.65-76 ,
DOI : 10.1016/j.canlet.2016.11.004
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer, Proc. Natl ,
DOI : 10.1002/pros.1111
URL : http://www.pnas.org/content/109/4/1127.full.pdf
A Subset of Host B Lymphocytes Controls Melanoma Metastasis through a Melanoma Cell Adhesion Molecule/MUC18-Dependent Interaction: Evidence from Mice and Humans, Cancer Research, vol.68, issue.20, pp.8419-8428, 2008. ,
DOI : 10.1158/0008-5472.CAN-08-1242
Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer, Br. J. Cancer, vol.110, pp.1236-1243, 2014. ,
CD146: a new partner for VEGFR2, Blood, vol.120, issue.11, pp.2164-2165 ,
DOI : 10.1182/blood-2012-07-439646
URL : http://www.bloodjournal.org/content/bloodjournal/120/11/2164.full.pdf
Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform, Cardiovascular Research, vol.15, issue.3, pp.240-251, 2016. ,
DOI : 10.1074/jbc.M407986200
URL : https://hal.archives-ouvertes.fr/hal-01456844
Soluble Melanoma Cell Adhesion Molecule (sMCAM/sCD146) Promotes Angiogenic Effects on Endothelial Progenitor Cells through Angiomotin, Journal of Biological Chemistry, vol.92, issue.13, pp.8991-9000, 2013. ,
DOI : 10.1111/j.1538-7836.2008.03214.x
URL : http://www.jbc.org/content/288/13/8991.full.pdf
Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells, Journal of Biological Chemistry, vol.6, issue.20, pp.8381-8389, 2017. ,
DOI : 10.18632/oncotarget.4409
CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood, Blood, vol.106, issue.8, pp.2923-2924, 2005. ,
DOI : 10.1182/blood-2005-06-2307
an activation antigen of human T lymphocytes, MUC18/MCAM (CD146), pp.2107-2115, 1997. ,
Mouse CD146/MCAM is a marker of natural killer cell maturation, European Journal of Immunology, vol.104, issue.10, pp.2855-2864, 2008. ,
DOI : 10.4049/jimmunol.180.6.3739
A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile, BMC Immunology, vol.8, issue.1, p.29, 2007. ,
DOI : 10.1186/1471-2172-8-29
Identification and functional assessment of endothelial P1H12, Journal of Laboratory and Clinical Medicine, vol.138, issue.5, pp.322-331, 2001. ,
DOI : 10.1067/mlc.2001.118519
Coexpression of CCR6 and CD146 (MCAM) is a marker of effector memory T-helper 17 cells, The Journal of Dermatology, vol.20, issue.10, pp.838-842, 2012. ,
DOI : 10.1111/j.1600-0625.2011.01308.x
MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread, Cancer Res, vol.54, pp.5689-5694, 1994. ,
S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen, Tissue Antigens, vol.93, issue.5, pp.531-539, 1996. ,
DOI : 10.1042/bj2590035
Identification of the S-Endo 1 Endothelial-Associated Antigen, Biochemical and Biophysical Research Communications, vol.218, issue.1, pp.210-216, 1996. ,
DOI : 10.1006/bbrc.1996.0037
A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo, Clin. Cancer Res, vol.9, pp.6560-6566, 2003. ,
Anti-CD146 monoclonal antibody AA98 inhibits angiogenesis via suppression of nuclear factor-??B activation, Molecular Cancer Therapeutics, vol.5, issue.11, pp.2872-2878, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0260
Generation and Characterization of a Panel of Monoclonal Antibodies Against Distinct Epitopes of Human CD146, Hybridoma, vol.27, issue.5, pp.345-352, 2008. ,
DOI : 10.1089/hyb.2008.0034
CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis, Blood, vol.120, issue.11, pp.2330-2339, 2012. ,
DOI : 10.1182/blood-2012-01-406108
Targeting CD146 in combination with vorinostat for the treatment of ovarian cancer cells, Oncology Letters, vol.13, issue.3, pp.1681-1687, 2017. ,
DOI : 10.3892/ol.2017.5630
Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis, Scientific Reports, vol.56, issue.1 ,
DOI : 10.1111/j.0006-341X.2000.00455.x
Radiopharmaceuticals as probes to characterize tumour tissue, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.26, pp.537-561, 2015. ,
DOI : 10.1038/nm.2935
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications, The Oncologist, vol.12, issue.12, pp.1379-1389, 2007. ,
DOI : 10.1634/theoncologist.12-12-1379
ImmunoPET to help stratify patients for targeted therapies and to improve drug development, European Journal of Nuclear Medicine and Molecular Imaging, vol.42, issue.12, pp.2166-2168, 2016. ,
DOI : 10.1007/s00259-015-3025-6
URL : https://link.springer.com/content/pdf/10.1007%2Fs00259-016-3458-6.pdf
PET versus SPECT: strengths, limitations and challenges, Nuclear Medicine Communications, vol.29, issue.3, pp.193-207, 2008. ,
DOI : 10.1097/MNM.0b013e3282f3a515
CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody, Theranostics, vol.2016, issue.6, 1918. ,
ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors, Molecular Pharmaceutics, vol.13, issue.7, pp.2563-2570, 2016. ,
DOI : 10.1021/acs.molpharmaceut.6b00372
ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.12, pp.2169-2179, 2016. ,
DOI : 10.1093/intimm/dxl110